< Takaisin hakutuloksiin

Kuznetsov, Sergey

Orcid -palvelun logo https://orcid.org/0000-0002-5662-9700
Senior Scientist, Institute for Molecular Medicine Finland

Avainsanat

BRCA1, GPRC5A, HTS, Rad51c, breast cancer

Affiliaatiot

Institute for Molecular Medicine Finland
Yksikkö
High Throughput Biomedicine Unit
Lähde: ORCID
Nimike
Senior Scientist 2018 -
University of Helsinki
Yksikkö
Institute for Molecular Medicine Finland (FIMM)
Lähde: ORCID
Nimike
FIMM-EMBL Group Leader 2008 - 2016
National Cancer Institute, NIH
Yksikkö
Mouse Cancer Genetics Program
Lähde: ORCID
Nimike
post-doc 2002 - 2008

Koulutus

Tutkinnot
MSc 1.9.1995 - 31.12.1997 / St. Petersburg State University
PhD 13.3.1998 - 13.3.2002 / University of Kiel
BSc 1.9.1990 - 30.6.1995 / St. Petersburg State University

Julkaisut (28)

P-TEFb promotes cell survival upon p53 activation by suppressing intrinsic apoptosis pathway
2023
DOI
10.1093/nar/gkad001
High-throughput compound screening identifies navitoclax combined with irradiation as a candidate therapy for HPV-negative head and neck squamous cell carcinoma.
2021
DOI
10.1038/s41598-021-94259-5
Response to: The GPRC5A frameshift variant c.183del is not associated with increased breast cancer risk in BRCA1 mutation carriers.
2019
DOI
10.1002/ijc.32013
Näytä kaikki

Rahoitusmyönnöt (4)

Identifying New Therapeutic Targets for Hereditary Breast CancersSuomen Akatemia2011 - 2016
IDENTIFYING NEW THERAPEUTIC TARGETS FOR HEREDITARY BREAST CANCERSSuomen Akatemia2011 - 2016
Developing personalized therapeutic approaches for BRCA1-mutated breast cancersCancer Society of Finland2011 - 2012
Näytä kaikki

Aktiviteetit ja palkinnot (1)

Functional Analysis of Human BRCA2 Variants Using a Mouse Embryonic Stem Cell-Based Assaymuu aktiviteetti2010
Lisätiedot